796 / 1224
/
OS
CSS
LE
SLR
Shirvani IJROBP 2012
• SBRT as low-risk option for patients >65 years old
SBRT: results of population based studies
SEER database: stage I NSCLC, age ≥65a: n=10.923
Safety
Efficacy
90 day death rate
SBRT
0.8 %
SLR
5.6 %
LE
4.1 %
M Guckenberger - SBRT stage I NSCLC - HICARE 2015
54